Form 8-K - Current report:
SEC Accession No. 0000912282-14-000432
Filing Date
2014-07-23
Accepted
2014-07-23 12:01:18
Documents
3
Period of Report
2014-07-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 antribio8k_07182014.htm 8-K 32357
2 PRESS RELEASE, DATED JULY 23, 2014 ex99_1.htm EX-99.1 12541
3 antriabiologo.jpg GRAPHIC 6720
  Complete submission text file 0000912282-14-000432.txt   55610
Mailing Address 890 SANTA CRUZ AVENUE MENLO PARK CA 94025
Business Address 890 SANTA CRUZ AVENUE MENLO PARK CA 94025 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54495 | Film No.: 14988229
SIC: 2834 Pharmaceutical Preparations